Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

by lowes1 on September 27, 2013

Condition:   Non-Small Cell Lung Cancer
Interventions:   Drug: Denosumab;   Drug: Zometa
Sponsors:   Amgen;   Amgen
Not yet recruiting – verified September 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: